Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
13.08.25
/
50%
€104.00
Target price
13.08.26
€121.61
Performance (%)
34.62%
Price
10.10.25
€141.00
Summary
This prediction is currently active. With a performance of 34.62% the BUY prediction by The_Goldman_Sachs_Gr is a big success. This prediction currently runs until 13.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 6.818% | 6.818% |
| iShares Core DAX® | -0.693% | 2.676% |
| iShares Nasdaq 100 | -1.173% | 2.362% |
| iShares Nikkei 225® | -1.388% | 3.465% |
| iShares S&P 500 | -1.411% | 1.137% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $114.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat